Stratasys Ltd. (NASDAQ:SSYS) revealed a staggering $938 million loss, and that consensus estimates were anticipating a loss of 12 cents per share of $168.31 million in revenue for Q4. Proving those estimates wrong, Stratasys today reported a loss of just 1 cent per share on revenue of $173.36 million in the fourth quarter of 2015.
Stratasys Ltd. (NASDAQ:SSYS) belongs to Technology sector. Its weekly performance is 46.63%. On last trading day company shares ended up at $27.64. Stratasys Ltd. (NASDAQ:SSYS) distance from 50-day simple moving average (SMA50) is 3.04%.
Real Industry, Inc. (NASDAQ:RELY) shares fell -5.35% in last trading session and ended the day at $7.08. RELY Gross Margin is 6.70% and its return on assets is 0.10%. Real Industry, Inc. (NASDAQ:RELY) quarterly performance is -31.06%.
On 29 February, Global Partners LP (NYSE:GLP) reported financial results for the fourth quarter and full year ended December 31, 2015.The net loss attributable to Global for the fourth quarter of 2015 was $2.3 million, or $0.07 per limited partner unit, compared with net income attributable to the Partnership of $27.9 million, or $0.93 per diluted limited partner unit, for the fourth quarter of 2014.
On 04 March, Global Partners LP (NYSE:GLP) shares fell -2.28% and was closed at $13.27. GLP EPS growth in last 5 year was 9.50%. Global Partners LP (NYSE:GLP) year to date (YTD) performance is -22.19%.
On 3 March, Vantiv, Inc. (NYSE:VNTV) has signed on to host the Welcome Cocktail Reception on the opening night of the annual Retail Realm Partner & User Conference. Known for its networking opportunities, the event will bring together Microsoft Dynamics staff, partners, ISVs, resellers and retailers in the Foundation Room at the Mandalay Bay in Las Vegas on August 21, 2016.
Vantiv, Inc. (NYSE:VNTV) ended the last trading day at $52.86. Company weekly volatility is calculated as 2.27% and price to cash ratio as 51.10. Vantiv, Inc. (NYSE:VNTV) showed a weekly performance of 1.32%.
On 1 March, Acasti Pharma Inc. (NASDAQ:ACST) announces the appointment of Dr. Roderick Carter, as Executive Chairman of the Board. At the same time Acasti announces the resignations of Jerald D. Wenker, Harlan W. Waksal, Adrian Montgomery and Reed V. Tuckson as directors of Acasti effective immediately while appointing Pierre Fitzgibbon as director of the Corporation. The Board of Directors intends to fill the remaining vacancies with individuals with relevant experience shortly.
Acasti Pharma Inc. (NASDAQ:ACST) shares fell -1.67% in last trading session and ended the day at $1.77. Acasti Pharma Inc. (NASDAQ:ACST) quarterly performance is -16.11%.